1e
19
1
49
2
2
18
1b
1d
18
32
50
1d
2 29
1d
25
Susan C. Brozena, MD
78
50
Emeritus Associate Professor CE of Medicine
28
68
3
5f
Medical Director, Cardiology Penn Medicine Radnor
11
Department: Medicine
4
1
b
1d
46
Contact information
42
4
3
3
1d
42
Penn Medicine Radnor
30 University of Pennsylvania Health System
35 250 King of Prussia Road
Radnor, PA 19087
26
30 University of Pennsylvania Health System
35 250 King of Prussia Road
Radnor, PA 19087
2e
Office: 610-902-2273
32 Fax: 610-902-2311
24
8f
32 Fax: 610-902-2311
24
Email:
brozenas@uphs.upenn.edu
12
brozenas@uphs.upenn.edu
18
Publications
23 a
3
2
29
4
b
1f
23 a
13
Education:
21 9 R.N. c
48 Wilkes-Barre General Hospital School of Nursing, 1972.
21 8 BSN c
27 Wilkes College, 1976.
21 7 MD c
2a Temple University, 1981.
c
3
3
3
3
8b
Permanent link21 9 R.N. c
48 Wilkes-Barre General Hospital School of Nursing, 1972.
21 8 BSN c
27 Wilkes College, 1976.
21 7 MD c
2a Temple University, 1981.
c
2 29
21
1e
1d
24
5e
65
17 Heart transplant
1a 29
27
Description of Research Expertise
3f Clinical trials in heart failure and transplant65
Description of Clinical Expertise
1e Heart failure17 Heart transplant
1a 29
23
b1 Jessup M, Brozena S: Support devices for end stage heart failure Cardiology Clinics 21: 135-139, 2003.
de Brozena SC, Jessup M: The new staging system for congestive heart failure: What every primary care physician should know. Geriatrics 58: 31-36, 2003.
164 Brozena S, Twomey C, Goldberg L, Desai S, Drachman B, Kao A, Popjes E, Zimmer R, Jessup M: A prospective study of out-patient continuous milrinone therapy In patients awaiting heart transplant. Heart Failure Society of America (HFSA) 7th Annual Scientific Meeting, Las Vegas NV 2003.
f2 Brozena, SC: Examination of the patient suspected to have heart failure. The Clinician’s Guide to Congestive Heart Failure. M Jessup, E Loh (eds.). Humana Press, 2003.
8c Brozena S, Jessup M.: "Heart failure: evaluation and treatment of systolic heart failure" d1 June 2003 Notes: CME accreditation program, computer-based for Internet presentation, for Graduate Education Foundation Pepper Pavilion- Graduate Hospital, Philadelphia PA., Submitted.
11d Israni A, Brozena S, Pankewycz O, Grossman R, Bloom R: Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients. Am J Kidney Diseases 39: E16.1-5, 2002.
ef Blumberg EA, Brozena SC, Stutman P, Wood D, Phan HM, Musher DM: Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Inf Dis 32: 307-310, 2001.
130 Blumberg EA, Lazar J, Rossino A, Brozena S, Twomey C, Bloom RD: Prophylactic use of antibiotics following heart and kidney transplantation. Accepted for presentation at Infectious Disease Society of America, San Francisco Oct 2001.
11a Izrailtyan I, Kresh Y, Morris R, Brozena SC: Early detection of acute allograft rejection using dimensional analysis of heart rate variability. Journal of Thoracic & Cardiovascular Surgery 120: 737-745, 2000.
2c
7
1d
1f
Selected Publications
a0 Jessup M, Brozena S: Medical Progress: Heart Failure. N Eng J Med 348: 2007-2018, 2003.b1 Jessup M, Brozena S: Support devices for end stage heart failure Cardiology Clinics 21: 135-139, 2003.
de Brozena SC, Jessup M: The new staging system for congestive heart failure: What every primary care physician should know. Geriatrics 58: 31-36, 2003.
164 Brozena S, Twomey C, Goldberg L, Desai S, Drachman B, Kao A, Popjes E, Zimmer R, Jessup M: A prospective study of out-patient continuous milrinone therapy In patients awaiting heart transplant. Heart Failure Society of America (HFSA) 7th Annual Scientific Meeting, Las Vegas NV 2003.
f2 Brozena, SC: Examination of the patient suspected to have heart failure. The Clinician’s Guide to Congestive Heart Failure. M Jessup, E Loh (eds.). Humana Press, 2003.
8c Brozena S, Jessup M.: "Heart failure: evaluation and treatment of systolic heart failure" d1 June 2003 Notes: CME accreditation program, computer-based for Internet presentation, for Graduate Education Foundation Pepper Pavilion- Graduate Hospital, Philadelphia PA., Submitted.
11d Israni A, Brozena S, Pankewycz O, Grossman R, Bloom R: Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients. Am J Kidney Diseases 39: E16.1-5, 2002.
ef Blumberg EA, Brozena SC, Stutman P, Wood D, Phan HM, Musher DM: Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Inf Dis 32: 307-310, 2001.
130 Blumberg EA, Lazar J, Rossino A, Brozena S, Twomey C, Bloom RD: Prophylactic use of antibiotics following heart and kidney transplantation. Accepted for presentation at Infectious Disease Society of America, San Francisco Oct 2001.
11a Izrailtyan I, Kresh Y, Morris R, Brozena SC: Early detection of acute allograft rejection using dimensional analysis of heart rate variability. Journal of Thoracic & Cardiovascular Surgery 120: 737-745, 2000.
2c